The rivalry between Moderna and Pfizer/BioNTech in commercialising ... but are "surprised by the litigation given the COVID-19 vaccine was based on BioNTech's proprietary mRNA technology and ...

Unlike countries such as the United Kingdom, Canada and Australia, the US alone recommends an annual Covid-19 vaccine for healthy younger adults and children. The World Health Organization also ...

multisystem inflammatory syndrome and COVID-19 vaccine uptake, the agency said. Outside medical groups have opposed scaling back recommendations for COVID-19 vaccines, citing concerns that the ...

Moderna says it has become the first company in the pharma sector with phase 3 data on a combined vaccine for both COVID-19 and influenza and will soon be ready to discuss “next steps” with ...

The program will run until June 30. An additional dose will be available to people who received a dose of a COVID-19 vaccine since fall 2024, provided it has been at least three months since that ...

As of April 5, less than a quarter of adults in the U.S. have gotten an updated COVID-19 vaccine. Millions worldwide have had long COVID-19, with dozens of widely varying symptoms, including ...

Seebaran, who received the Pfizer Covid- 19 vaccine on October 6, 2021, took her life two years later on May 25, 2023, after her health deteriorated, leaving her paralysed and dependent on her ...

Six patients had received adenoviral vector-based vaccines (four received AstraZeneca and two received Janssen), and the others had mRNA-based vaccines (five had Pfizer and one had Moderna). All but ...

Between May 1 and June 30, the province will make additional COVID-19 vaccine doses available for people who have already had a dose since last fall, but meet specific criteria. The extra doses ...